Results 11 to 20 of about 15,294 (209)

RIPK3 and kidney disease

open access: yesNefrología (English Edition), 2023
Receptor interacting protein kinase 3 (RIPK3) is an intracellular kinase at the crossroads of cell death and inflammation. RIPK3 contains a RIP homotypic interaction motif (RHIM) domain which allows interactions with other RHIM-containing proteins and a ...
Juan Guerrero-Mauvecin   +4 more
doaj   +9 more sources

PRMT5-mediated regulatory arginine methylation of RIPK3

open access: yesCell Death Discovery, 2023
The TNF receptor-interacting protein kinases (RIPK)-1 and 3 are regulators of extrinsic cell death response pathways, where RIPK1 makes the cell survival or death decisions by associating with distinct complexes mediating survival signaling, caspase ...
Chanchal Chauhan   +7 more
doaj   +6 more sources

RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease

open access: yesHepatology, EarlyView., 2022
RIPK3 dampens mitochondrial bioenergetics and lipid droplet dynamics in metabolic liver disease. Abstract Background and Aims Receptor‐interacting protein kinase 3 (RIPK3) mediates NAFLD progression, but its metabolic function is unclear. Here, we aimed to investigate the role of RIPK3 in modulating mitochondria function, coupled with lipid droplet (LD)
Marta B. Afonso   +16 more
wiley   +3 more sources

RIPK3 Suppresses the Progression of Spontaneous Intestinal Tumorigenesis [PDF]

open access: yesFrontiers in Oncology, 2021
Receptor-interacting protein 3 (RIPK3), a member of the family of serine/threonine protein kinases, emerged as a critical regulator of necroptosis. Downregulated expression of RIPK3 is correlated with poor prognosis in multiple tumor types. Here, we show
Qun Zhao   +12 more
doaj   +3 more sources

Human RIPK3 C-lobe phosphorylation is essential for necroptotic signaling

open access: yesCell Death and Disease, 2022
Necroptosis is a caspase-independent, pro-inflammatory mode of programmed cell death which relies on the activation of the terminal effector, MLKL, by the upstream protein kinase RIPK3.
Yanxiang Meng   +7 more
doaj   +2 more sources

RIPK1 and RIPK3 - emerging targets in cancer?

open access: yesMolecular and Cellular Therapies, 2018
RIPK1 and RIPK3 are homologous Ser/Thr kinases, which act in concert within the necrosome complexes to initiate a sub-type of regulated necrosis, termed necroptosis.
Suraj Shah, Kerem Gurol, Alexei Degterev
core   +3 more sources

RIPK3 Contributes to Thyroid Hormone-Induced Photoreceptor Degeneration [PDF]

open access: yesInternational Journal of Molecular Sciences
Thyroid hormone (TH) regulates cell proliferation, differentiation, and metabolism. Increased TH levels in circulation are associated with a higher incidence of age-related macular degeneration.
Yun Le   +9 more
core   +3 more sources

Distinct Kinase-Independent Role of RIPK3 in CD11c+ Mononuclear Phagocytes in Cytokine-Induced Tissue Repair [PDF]

open access: yesCell Reports, 2017
Receptor interacting protein kinase 3 (RIPK3) induces necroptosis, a type of regulated necrosis, through its kinase domain and receptor interacting protein (RIP) homotypic interaction motif (RHIM).
Kenta Moriwaki   +4 more
doaj   +3 more sources

Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis [PDF]

open access: yesNature Communications, 2021
The pseudokinase MLKL is activated by the upstream kinase RIPK3 in the necroptotic pathway but the structural basis of MLKL activation is not well understood yet.
Yanxiang Meng   +14 more
doaj   +2 more sources

Spotted: RIPK3 and MLKL assembling necroptotic complexes

open access: yesOpen Biology
Necroptosis is a form of regulated cell death (RCD) that evolved as a defence against pathogenic infection. Unlike caspase-dependent RCD, necroptosis, in its canonical form, is driven by receptor-interacting protein kinase 1 and 3 (RIPK1 and RIPK3 ...
Martínez-Osorio, V.   +2 more
core   +4 more sources

Home - About - Disclaimer - Privacy